Madalina Gabriela Indre

Joint PhD - University of Medicine and Pharmacy "Iuliu Hatieganu", Cluj-Napoca, Romania and Alma Mater Studiorum - Università di Bologna, Italy

[Madalina Gabriela Indre @md_linaa]

In adults with BSEP deficiency acute attacks of isolated or recurrent cholestasis may be triggered not only by specific medications but also by external factors, including infections such as B19. Here's an illustrative case. https://t.co/72QEuDItic #BSEP #Cholestasis #RareDisease

[HEPATOLOGY Journal @HEP_Journal]

Artículo original

Precisión diagnóstica de la ecografía 2D-SWE para la evaluación de la fibrosis hepática en MASLD: un metanálisis con modelo multinivel de efectos aleatorios

Indre et al.
#LiverX
https://t.co/NGZeFv4wUJ

[Laura Turco @Laura_Turco83]

NSSB do lower the risk of first decompensation even in patients with cirrhosis and treated etology!

Thank you @JosephHabibi_MD for highlighting our study!
@AGA_CGH
@md_linaa
@BavenoCoop

[Madalina Gabriela Indre @md_linaa]

📢 Exciting news! Our multilevel random-effects model meta-analysis, aimed at standardizing 2D-SWE ultrasound for MASLD across various clinical scenarios, is now available in full text in @HEP_Journal!
🔍 This study marks an important step toward harmonizing ultrasound-based liver stiffness measurements in clinical practice.
📖 Read the full article here: https://t.co/UoGdACnwXN

🔹 Why This Study Is a Milestone
✔️ First-ever multilevel meta-analysis of 2D-SWE in MASLD
✔️ Largest pooled cohort to date (2,223 patients with biopsy-proven MASLD)
✔️ Independent validation of the WFUMB 2024 "Rule of 4"
✔️ Highlights the role of 2D-SWE, especially SSI, as a non-invasive, reliable tool for fibrosis staging

@FedRavaioli @Laura_Turco83 @horstef @bogdanprocopet @FabioPiscaglia

[Madalina Gabriela Indre @md_linaa]

Honored to present at #SLDSummit2025 in beautiful Estoril! Shared insights from Bologna, Italy @Unibo on HCC screening in MASLD using SuperSonic Imagine 2D-SWE. Enthusiastic about the preliminary results! #HCC #MASLD #2DSWE #Liverx #BLISS @FedRavaioli @BeStef33 @FabioPiscaglia

[Madalina Gabriela Indre @md_linaa]

The full text of our multi-level random effects model meta-analysis will soon be available online! Keep an eye out 🎉 @FedRavaioli @Laura_Turco83 @horstef @bogdanprocopet @FabioPiscaglia #livertwitter #liverx @AASLDtweets @EASLnews

[HEPATOLOGY Journal @HEP_Journal]

Original Article
Diagnostic accuracy of 2D-SWE ultrasound for liver fibrosis assessment in MASLD: A multi-level random effects model meta-analysis
Taru et al.
#LiverX
https://t.co/Rb2SgxFWS1

[HEPATOLOGY Journal @HEP_Journal]

Original Article
Diagnostic accuracy of 2D-SWE ultrasound for liver fibrosis assessment in MASLD: A multi-level random effects model meta-analysis
Taru et al.
#LiverX
https://t.co/Rb2SgxFWS1

[EASLnews @EASLnews]

⏰ The EASL #SLDSummit 2025 is just around the corner, taking place NEXT WEEK!

📅 23-25 January 2025, Estoril, Portugal & online.

If you want to recharge your SLD research batteries, increase the quality level of your clinical SLD practice, or simply fuel your knowledge with the newest information: you are still in time to join us!

It’s time to finalise your plans and get ready for an incredible event!
👉 https://t.co/M0YcT1RuFC

[Federico Ravaioli @FedRavaioli]

Honoured to present at #EUROSON in Napoli our multilevel random-effects meta-analysis to establish standardized cut-off values for 2D-SWE in different stages of #liver fibrosis in biopsy-proven #MASLD. This could be a game-changer in #ultrasound

[Laura Turco @Laura_Turco83]

Check-out our last article!
🔽
β-blockers lower first decompensation in patients with cirrhosis and enduring portal hypertension after etiological treatment.

@MadalinaTaru
@horstef
@bogdanprocopet
@BavenoCoop

https://t.co/SoGEQOOPEZ

[Madalina Gabriela Indre @md_linaa]

Diagnostic accuracy of 2D-SWE in biopsy-proven MASLD
Potential to standardise cut-offs ✌️
#EASLCongress2024
@Laura_Turco83 @FedRavaioli @horstef @bogdanprocopet
#BolognaLiverGroup

[Madalina Gabriela Indre @md_linaa]

#EASLCongress 😆

[Laura Turco @Laura_Turco83]

Skill learning center on liver and spleen stiffness! 🤩
Come and put your hands on the new machines!
🔽
@MadalinaTaru @FedRavaioli @EltonDajti

[Laura Turco @Laura_Turco83]

Happy smiles of the #BolognaLiverGroup for @easl congress just started in Milan!
@Zac_MD @FedRavaioli @EltonDajti @MadalinaTaru ❤️

[Thomas Reiberger @ReibergerThomas]

@bavenocoop study
published in @JHepatology
📕https://t.co/zFz3sD3U6S
right before @EASLnews congress 2024

#PortalPressure #HVPG predicts #decompensation in #MASLD #MASH cirrhosis

#HVPG_10 #CSPH and #HVPG_16 indicate a stepwise increase in #liver-related events death

[Thomas Reiberger @ReibergerThomas]

🙏the credit for this study goes out to many collaborators across several European centers
@BenediktHofer @FrancqueSven @MattiasMandorf1 @MPraktiknjo @VladTaruMD @RafaelBanares @christianjansen @HeleneLarrue @FrancqueSven
and many more not "taggable" on #TwitterX" - see list

[Madalina Gabriela Indre @md_linaa]

Validation of the Agile 3+, Agile 4 and FAST scores for East Europe ✅
https://t.co/kBmQDCAEft
@horstef @bogdanprocopet

[Madalina Gabriela Indre @md_linaa]

#LiverTwitter, exciting news! 🎉 My abstract has been accepted for #EASLCongress 2024 in Milan, Italy, from June 5-8. I hope to see you there – secure your spot now and let's revolutionise liver science together! 💡👩‍🔬 https://t.co/OG6ukkVhLh @EASLNews

[Laura Turco @Laura_Turco83]

Repeat after me:
▶️ Plasma transfusion should be avoided for all paracenteses and diagnostic endoscopy!🚫

A must read paper by the one and only @ebtapper

https://t.co/iCDPmuI3fG

[Madalina Gabriela Indre @md_linaa]

Happy to have contributed to this work while learning from the best ! ❤️

[Chiara Becchetti @BecchettiChiara]

Happening now @AisfFegato meeting. @Laura_Turco83 presents important data on the benefit of NSBB in all decompensation events in a large cohrt of compensated patients. 📣📣 @BavenoCoop @ggarciatsao @jaumebosch9 @tho